A. Bouska

Type de document

Co-auteur

H.G. Wendel

T. Walzer

A. Viale

A. Verney

M. Urb

A Traverse-Glehen

J. Teruya-Feldstein

W. Tam

P. Sujobert

D. Sibon

S Sharma

V.E. Seshan

J.H. Schatz

C. Sander

G. Salles

J.P. Rouault

R. Robinot

R.M. Pommier

E. Oricchio

T. McKeithan

S. Mareschal

A. Marçais

C. Lours

C. Lefebvre

E. Julia

M Jiang

J. Iqbal

M. Heiblig

A. Heguy

L. Genestier

P Gaulard

C. Fezelot

A. Ferrari

E. de Stanchina

L. De Leval

L Courtois

G. Ciriello

A. Chebel

D. Chartoire

W.C. Chan

R.S. Chaganti

S. Carras

M.H. Boice

M. Blery

C. Bertheau

E. Bardel

E. Bachy

Date

Source

Serveur académique Lausannois (2)

Mot-clé

modèle (2) Mice (2) Lymphomas (2) Example (2) thérapie (1) besoin (1) perte (1) immunologie (1) maladie (1) ligne (1) cancer (1) index (1) survie (1) Treatment (1) Blockades (1) Chemotherapy (1) Cancer (1) Inhibitors (1) Phenotype (1) Tumors (1) Therapeutics (1) T cells (1) Survival (1) Retinoblastoma (1) Proteins (1) Molecules (1) Human beings (1) Lymphocyte transformation (1) Inhibition (1) Immunology (1)

Documents écrit par A. Bouska (2) | parle de A. Bouska (0)

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.

S. Carras et al. (1 juil. 2021)

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.

E. Oricchio et al. (30 juin 2014)